FeesSafety
Pluang+

Alterity Therapeutics to present at Bell Potter Healthcare Conference on Nov 19, highlighting neurodegenerative disease treatments.

Market News
12 Nov 2026, 14:05 WIB
GlobeNewsWire
View Source
Bullish
Alterity Therapeutics to present at Bell Potter Healthcare Conference on Nov 19, highlighting neurodegenerative disease treatments.

Alterity Therapeutics, a biotech company focused on neurodegenerative diseases, announced that CEO David Stamler will present at the virtual Bell Potter Healthcare Conference on November 19, 2026. The company is preparing for a Phase 3 trial of its lead drug ATH434 for Multiple System Atrophy (MSA), a rare neurodegenerative disease with no approved treatments. Positive Phase 2 trial results support the drug's potential. The presentation will provide updates on their progress and future plans in developing disease-modifying therapies for Parkinson’s and related disorders.

Alterity Therapeutics' upcoming presentation at the Bell Potter Healthcare Conference provides context for health sector activity on Pluang. For readers following health stocks, here is Pluang's market snapshot as of Nov 12, 2026 18:11 WIB: out of 150 priced US health-sector stocks, 84 rose and 57 fell. Notable movers include SANA at USD 2.41 with a 5.24% increase and a typical hold time of 26 days, BNGO at USD 1.15 up 4.55% with a 52-day hold, and MMED at USD 17.50 down 4.11% with a 19-day hold.

More News

Tilray's 10 Barrel, Widmer Brothers, and Hop Valley named official craft beer partners of Portland Trail Blazers.

Tilray's 10 Barrel, Widmer Brothers, and Hop Valley named official craft beer partners of Portland Trail Blazers.

Tilray Brands announced that its subsidiaries 10 Barrel Brewing, Widmer Brothers Brewing, and Hop Valley Brewing are now the official craft beer partners of the Portland Trail Blazers. This partnership expands the availability of Oregon craft beers a...

Market News
Bullish
22 minutes ago
Titan Mining's nine-month Adjusted EBITDA jumps 146% to $19.8M, advancing U.S. critical minerals projects.

Titan Mining's nine-month Adjusted EBITDA jumps 146% to $19.8M, advancing U.S. critical minerals projects.

Titan Mining reported a 146% increase in nine-month Adjusted EBITDA to $19.8 million, driven by a 38% rise in revenue to $67.9 million. Despite some production delays, zinc output is expected to improve in Q4 2026. The company is progressing its U.S....

Company Fundamentals
Bullish
1 hour ago
Nexpu completes delivery of 10,000 resale robots worth $4.8M under existing contract

Nexpu completes delivery of 10,000 resale robots worth $4.8M under existing contract

Nexpu Ltd.'s subsidiary, Top Kingwin Hi Tech Inc., has finished delivering all 10,000 TK-D2C robots to Walkers Times International under a $4.8 million resale contract signed in 2025. The deliveries were completed in batches, with the final 5,000 uni...

Market News
Bullish
1 hour ago
Katapult Holdings reports Q3 2026 results with $753.9M revenue, $110.4M adjusted EBITDA, and $30M cost synergies from merger.

Katapult Holdings reports Q3 2026 results with $753.9M revenue, $110.4M adjusted EBITDA, and $30M cost synergies from merger.

Katapult Holdings announced its third quarter 2026 financial results, reporting total revenues of $753.9 million and an adjusted EBITDA of $110.4 million, reflecting a 23% increase year-over-year on a combined basis. The company completed a merger wi...

Company Fundamentals
Neutral
1 hour ago
Three-quarters of U.S. workers plan to freelance within 3 years, valuing independence over salary.

Three-quarters of U.S. workers plan to freelance within 3 years, valuing independence over salary.

A new report from Fiverr reveals that 81% of full-time U.S. employees want to become their own boss, with 42% prioritizing independence over higher pay. This trend, dubbed "The Great Flexit," shows workers quietly preparing to freelance by building A...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App